Promoting optimal use of beta-blockers after myocardial infarction

Outcomes of patients treated through the Canadian Fabry disease initiative.

Molecular genetics and metabolism·2014

Baseline characteristics of patients enrolled in the Canadian Fabry Disease Initiative.

Molecular genetics and metabolism·2009

Neurotoxic, hemorrhagic and proteolytic activities of Duvernoy's gland secretion from Venezuelan opisthoglyphous colubrid snakes in mice.

Veterinary and human toxicology·2004

Formularies in integrated health systems: Fallon Healthcare System.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1996

Formulary evaluation of third-generation cephalosporins using decision analysis.

American journal of hospital pharmacy·1988

Evaluation of amitriptyline use for depression when prescribed by internists and psychiatrists.

Hospital formulary·1984

Impact of an electronic documentation system on timeliness and ancillary task completion.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Thigh abscess following alternate-site continuous glucose monitoring sensor placement.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Moving beyond a tale of two genes: Strides in management of metastatic gastrointestinal stromal tumors and their supportive care.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.

JACC. Heart failure·2026

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Circulation·2026

Development and External Validation of the GLORIA-AF Bleeding Weighted Risk Score for Patients with Atrial Fibrillation.

European journal of preventive cardiology·2026

Related Experiment Videos

Promoting optimal use of beta-blockers after myocardial infarction

Related Concept Videos

Outcomes of patients treated through the Canadian Fabry disease initiative.

Baseline characteristics of patients enrolled in the Canadian Fabry Disease Initiative.

Neurotoxic, hemorrhagic and proteolytic activities of Duvernoy's gland secretion from Venezuelan opisthoglyphous colubrid snakes in mice.

Formularies in integrated health systems: Fallon Healthcare System.

Formulary evaluation of third-generation cephalosporins using decision analysis.

Evaluation of amitriptyline use for depression when prescribed by internists and psychiatrists.

Impact of an electronic documentation system on timeliness and ancillary task completion.

Thigh abscess following alternate-site continuous glucose monitoring sensor placement.

Moving beyond a tale of two genes: Strides in management of metastatic gastrointestinal stromal tumors and their supportive care.

The role of pharmacy in advancing evidence-based tobacco use treatment in the Veterans Health Administration.

Improving patient safety with triple-scan technology for insulin pen administration.

Challenges in evaluating associations among vasopressors, enteral nutrition, and nonocclusive mesenteric ischemia.

Timely Carotid Revascularization to Prevent Stroke After Left Common Carotid Artery Occlusion During TEVAR.

Acute Anterior ST-Segment Elevation Myocardial Infarction Due to Left Atrial Myxoma Embolization.

Hydroxychloroquine-Induced Cardiotoxicity in the Setting of a False Positive PYP Scan.

Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Development and External Validation of the GLORIA-AF Bleeding Weighted Risk Score for Patients with Atrial Fibrillation.

Related Experiment Videos

Promoting optimal use of beta-blockers after myocardial infarction

Related Concept Videos

Related Articles